Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.325 USD | -10.47% | -16.14% | +31.19% |
Mar. 04 | Passage Bio, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Mar. 04 | Passage Bio, Inc. Appoints Kathleen Borthwick as Chief Financial Officer | CI |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 81.64M |
---|---|---|---|---|---|
Net income 2024 * | -76M | Net income 2025 * | -89M | EV / Sales 2024 * | - |
Net cash position 2024 * | 51.6M | Net cash position 2025 * | - | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-1.08
x | P/E ratio 2025 * |
-1.36
x | Employees | 58 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.51% |
Latest transcript on Passage Bio, Inc.
1 day | -10.47% | ||
1 week | -16.14% | ||
Current month | +2.71% | ||
1 month | -1.12% | ||
3 months | +31.19% | ||
6 months | +100.76% | ||
Current year | +31.19% |
Managers | Title | Age | Since |
---|---|---|---|
William Chou
CEO | Chief Executive Officer | 51 | 22-10-09 |
James M. Wilson
FOU | Founder | - | 17-06-30 |
Director of Finance/CFO | 48 | 21-10-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Maxine Gowen
CHM | Chairman | 66 | 21-02-17 |
Saqib Islam
BRD | Director/Board Member | 54 | 19-03-28 |
Director/Board Member | 52 | 20-01-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 2 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
24-05-14 | 1.325 | -10.47% | 131,504 |
24-05-13 | 1.48 | +0.68% | 32,392 |
24-05-10 | 1.47 | +0.68% | 60,663 |
24-05-09 | 1.46 | -2.67% | 82,629 |
24-05-08 | 1.5 | -5.06% | 187,112 |
Delayed Quote Nasdaq, May 14, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+31.19% | 81.64M | |
+5.33% | 111B | |
+12.11% | 106B | |
-12.56% | 22.24B | |
-3.70% | 21.25B | |
-6.03% | 18.97B | |
-35.21% | 18.52B | |
-10.86% | 16.81B | |
+5.10% | 13.94B | |
+37.57% | 12.54B |
- Stock Market
- Equities
- PASG Stock